OneVentures
Team Portfolio Funds Entrepreneurs Blog News Investors
TeamPortfolioFundsEntrepreneursBlogNewsInvestors
OneVentures

Could Vaxxas’ tiny patches enable a better COVID-19 vaccine?

 

Read more from Drug Delivery Business below.

Learn more
 
Drug Delivery BusinessCarolyn MillerSeptember 8, 2020Vaxxas, Paul Kelly
Twitter LinkedIn0 0 Likes
Previous

Vaxxas Announces $22 Million Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response

Media ReleaseCarolyn MillerOctober 6, 2020Paul Kelly, Vaxxas
Next

How Shippit got lean and profitable during COVID

The AustralianCarolyn MillerAugust 25, 2020Shippit, Michelle Deaker, Nick Gainsley

Suite 13.02, 179 Elizabeth Street, Sydney NSW 2000

enquiries@one-ventures.com

+61 2 8205 7379

Disclaimer

Responsible Investment Policy

Privacy Policy

 
 
OneVentures Pty Ltd
179 Elizabeth Street (Suite 13.02),
Sydney, NSW, 2000,
Australia
+61 2 8205 7379 enquiries@one-ventures.com
Hours

Copyright © 2017 OneVentures Pty Ltd